Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 271 AL 285

Immunotherapy for Alzheimer disease: the challenge of adverse effects

Liu YH, Giunta B, Zhou HD, Tan J, Wang YJ.

Nat Rev Neurol. 2012 Aug;8(8):465-9. doi: 10.1038/nrneurol.2012.118. Epub 2012 Jul 3.

The link between altered cholesterol metabolism and Alzheimer's disease

Gamba P, Testa G, Sottero B, Gargiulo S, Poli G, Leonarduzzi G.

Ann N Y Acad Sci. 2012 Jul;1259:54-64. doi: 10.1111/j.1749-6632.2012.06513.x.

Biochemistry and cell biology of tau protein in neurofibrillary degeneration

Mandelkow EM, Mandelkow E.

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006247. doi: 10.1101/cshperspect.a006247.

Neurotoxicity of amyloid β-protein: synaptic and network dysfunction

Mucke L, Selkoe DJ.

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338. doi: 10.1101/cshperspect.a006338.

The serotonergic system in ageing and Alzheimer's disease

Rodríguez JJ, Noristani HN, Verkhratsky A.

Prog Neurobiol. 2012 Oct;99(1):15-41. doi: 10.1016/j.pneurobio.2012.06.010. Epub 2012 Jul 2.

Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors

Kang J, Rivest S.

Endocr Rev. 2012 Oct;33(5):715-46. doi: 10.1210/er.2011-1049. Epub 2012 Jul 5.

Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial

Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ.

J Alzheimers Dis. 2012;31(1):225-36. doi: 10.3233/JAD-2012-121189.

New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration

Goldman JS.

Curr Neurol Neurosci Rep. 2012 Oct;12(5):502-10. doi: 10.1007/s11910-012-0296-1.

Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis

Pi Y, Zhang L, Chang K, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J.

Neurosci Lett. 2012 Aug 15;523(2):174-9. doi: 10.1016/j.neulet.2012.06.071. Epub 2012 Jul 7.

Validity of auditory verbal learning test in diagnosis of Alzheimer's disease

Hong X, Zhang ZX, Wu LY, Shi LL, Zhao XH, Wei J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Jun;34(3):262-6. doi: 10.3881/j.issn.1000-503X.2012.03.014.

Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease

Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M.

Nutr Neurosci. 2012 Nov;15(6):278-82. doi: 10.1179/1476830512Y.0000000027.

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ

Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul R, Pfeifer A, Muhs A, Watts RJ.

J Neurosci. 2012 Jul 11;32(28):9677-89. doi: 10.1523/JNEUROSCI.4742-11.2012.

Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: from animal models to human findings

D'Amelio M, Rossini PM.

Prog Neurobiol. 2012 Oct;99(1):42-60. doi: 10.1016/j.pneurobio.2012.07.001. Epub 2012 Jul 10.

Insulin: an emerging treatment for Alzheimer's disease dementia?

Morris JK, Burns JM.

Curr Neurol Neurosci Rep. 2012 Oct;12(5):520-7. doi: 10.1007/s11910-012-0297-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias